Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 217(2020) vom: 15. Aug., Seite 108480
Auteur principal: Vojdani, Aristo (Auteur)
Autres auteurs: Kharrazian, Datis
Format: Article en ligne
Langue:English
Publié: 2020
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Letter Antibodies, Viral Autoantibodies Autoantigens COVID-19 Vaccines Coronavirus Nucleocapsid Proteins Nucleocapsid Proteins Phosphoproteins Pulmonary Surfactant-Associated Proteins Spike Glycoprotein, Coronavirus plus... Viral Vaccines nucleocapsid phosphoprotein, SARS-CoV-2 spike protein, SARS-CoV-2
LEADER 01000caa a22002652c 4500
001 NLM310431271
003 DE-627
005 20250227082622.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2020.108480  |2 doi 
028 5 2 |a pubmed25n1034.xml 
035 |a (DE-627)NLM310431271 
035 |a (NLM)32461193 
035 |a (PII)S1521-6616(20)30425-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Vojdani, Aristo  |e verfasserin  |4 aut 
245 1 0 |a Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 21.07.2020 
500 |a Date Revised 22.02.2021 
500 |a published: Print-Electronic 
500 |a CommentIn: Clin Immunol. 2021 Mar;224:108665. doi: 10.1016/j.clim.2021.108665. - PMID 33429060 
500 |a Citation Status MEDLINE 
650 4 |a Letter 
650 7 |a Antibodies, Viral  |2 NLM 
650 7 |a Autoantibodies  |2 NLM 
650 7 |a Autoantigens  |2 NLM 
650 7 |a COVID-19 Vaccines  |2 NLM 
650 7 |a Coronavirus Nucleocapsid Proteins  |2 NLM 
650 7 |a Nucleocapsid Proteins  |2 NLM 
650 7 |a Phosphoproteins  |2 NLM 
650 7 |a Pulmonary Surfactant-Associated Proteins  |2 NLM 
650 7 |a Spike Glycoprotein, Coronavirus  |2 NLM 
650 7 |a Viral Vaccines  |2 NLM 
650 7 |a nucleocapsid phosphoprotein, SARS-CoV-2  |2 NLM 
650 7 |a spike protein, SARS-CoV-2  |2 NLM 
700 1 |a Kharrazian, Datis  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 217(2020) vom: 15. Aug., Seite 108480  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnas 
773 1 8 |g volume:217  |g year:2020  |g day:15  |g month:08  |g pages:108480 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2020.108480  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 217  |j 2020  |b 15  |c 08  |h 108480